Article
UN health agency set to receive 50 million H1N1 vaccines for developing countries
A giant pharmaceutical company is slated to donate 50 million doses of the pandemic H1N1 vaccine to the United Nations public health arm, the World Health Organization (WHO) announced today. Under a new agreement signed with GlaxoSmithKline, WHO expects to receive the first shipments of the vaccine by the end of November. WHO has a list of 95 developing countries that are eligible to receive donated vaccines, and aims to secure enough vaccines to cover 10 per cent of the population of these countries.